1. Home
  2. JAGX vs CNSP Comparison

JAGX vs CNSP Comparison

Compare JAGX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.06

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$5.49

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
CNSP
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
3.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JAGX
CNSP
Price
$1.06
$5.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$60.00
$20.00
AVG Volume (30 Days)
290.1K
21.4K
Earning Date
11-17-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,785,000.00
N/A
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.45
N/A
52 Week Low
$0.92
$4.93
52 Week High
$33.25
$114.00

Technical Indicators

Market Signals
Indicator
JAGX
CNSP
Relative Strength Index (RSI) 43.83 37.49
Support Level $0.92 $5.20
Resistance Level $1.14 $6.17
Average True Range (ATR) 0.11 0.53
MACD 0.01 -0.09
Stochastic Oscillator 40.06 14.83

Price Performance

Historical Comparison
JAGX
CNSP

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: